Do-it-yourself heart health? ‘Lay’ practices and products for disease prevention

References

• Abraham, J. (2007). From evidence to theory – Neo-liberal corporate bias as a framework for understanding UK pharmaceuticals regulation. Social Theory and Health, 5(2), 161–175.
   Google Scholar
• Backett, K., Davison, C., & Mullen, K. (1994). Lay evaluation of health and healthy lifestyles: Evidence from three studies. British Journal of General Practice, 44, 277–280.
   Google Scholar
• Berg, M. (1992). The construction of medical-disposals. Sociology of Health and Illness, 14(2), 151–180.
   Google Scholar
• Callon, M., & Rabeharisoa, V. (2004). Gino’s lesson on humanity: Genetics, mutual entanglements and the sociologist’s role. Economy and Society, 33(1), 1–27.
   Google Scholar
• Crawford, R. (1977). You are dangerous to your health: The ideology and politics of victim blaming. International Journal of Health Services, 7(4), 663–680.
   Google Scholar
• Crinson, I., Shaw, A., Durrant, R., De Lusignan, S., & Williams, B. (2007). Coronary heart disease and the management of risk. Health, Risk and Society, 9(4), 359–373.
   Google Scholar
• Davison, C., Frankel, S., & Smith, D. G. (1992). The limits of lifestyle: Re-assessing ‘fatalism’ in the popular culture of illness prevention. Social Science & Medicine, 34(6), 675–685.
   Google Scholar
• Davison, C., Smith, D. G., & Frankel, S. (1991). Lay epidemiology and the prevention paradox: The implications of coronary candidacy for health education. Sociology of Health & Illness, 13(1), 1–19.
   Google Scholar
• Davison, C., Frankel, S., & Smith, D. G. (1989). Inheriting heart trouble: The relevance of common-sense ideas to preventative measures. Health Education Research, 4(3), 329–340.
   Google Scholar
• Department of Health. (2004). Heart drug available without prescription. Retrieved from http://www.dh.gov.uk/en/Publicationsandstatistics/Pressreleases/DH_4082004
   Google Scholar
• Edgley, A. (2007). ‘A spoonful of regulation helps the medicine go down’: The changing face of medicine regulation. Social Theory and Health, 5(2), 145–160.
   Google Scholar
• Garrety, K. (1997). Social worlds, actor-networks and controversy: The case of cholesterol, dietary fat and heart disease. Social Studies of Science, 27(5), 727–773.
   Google Scholar
• Hammersley, M., & Atkinson, P. (1995). Ethnography: Principles in practice. London, England: Routledge.
   Google Scholar
• Hansen, D. L., & Hansen, E. H. (2006). Caught in a balancing act: Parents’ dilemmas regarding their ADHD child’s treatment with stimulant medication. Qualitative Health Research, 16(9), 1267–1285.
   Google Scholar
• Hunt, K., Davison, C., Emslie, C., & Ford, G. (2000). Are perceptions of a family history of heart disease related to health-related attitudes and behaviour? Health Education Research, 15(2), 131–143.
   Google Scholar
• Irwin, A., Dale, A., & Smith, D. (1996). Science and Hell’s kitchen: The Local understanding of hazard issues. In A. Irwin, & B. Wynne, (Eds.), Misunderstanding science?: The Public reconstruction of science and technology (pp. 47–64). Cambridge, England: Cambridge University Press.
   Google Scholar
• Lang, T. (2007). Functional foods. British Medical Journal (Clinical Research Ed.), 334(7602), 1015–1016.
   Google Scholar
• Lupton, D., & Chapman, S. (1995). ‘A healthy lifestyle might be the death of you’: Discourses on diet, cholesterol control and heart disease in the press and among the lay public. Sociology of Health & Illness, 17(4), 477–494.
   Google Scholar
• Moen, J., Bohm, A., & TUlenius, T. (2009). ‘I don’t know how many of these [medicines] are necessary…’. A focus group study among elderly users of multiple medicines. Patient Education and Counselling, 74(2), 135–141.
   Google Scholar
• Moncrieff, J. (2007). Response to ‘a spoonful of regulation helps the medicine go down’. Social Theory and Health, 5(2), 176–179.
   Google Scholar
• Moynihan, R., & Cassels, A. (2006). Selling sickness: How the world’s biggest pharmaceutical companies are turning us all into patients. New York, NY: Nation Books.
   Google Scholar
• Nichter, M., & Thompson, J. J. (2006). For my wellness, not just my illness: North Americans’ use of dietary supplements. Culture, Medicine and Psychiatry, 30, 175–222.
   Google Scholar
• Nørreslet, M., Bissell, P., & Traulsen, J. M. (2010). From consumerism to active dependence: Patterns of medicines use and treatment decisions among patients with atopic dermatitis. Health, 14(1), 91–106.
   Google Scholar
• Pound, P., Britten, N., Morgan, M., Yardley, L., Pope, C., Daker-White, G., & Campbell, R. (2005). Resisting medicines: A synthesis of qualitative studies of medicine taking. Social Science & Medicine, 61(1), 133–155.
   Google Scholar
• Prior, L. (2003). Belief, knowledge and expertise: The emergence of the lay expert in medical sociology. Sociology of Health & Illness, 25(1), 41–57.
   Google Scholar
• Radcliffe, P. (2011). Motherhood, pregnancy, and the negotiation of identity: The moral career of drug treatment. Social Science and Medicine, 72(6), 984–991.
   Google Scholar
• Radley, A., & Billig, M. (1996). Accounts of health and illness: Dilemmas and representations. Sociology of Health & Illness, 18(2), 220–240.
   Google Scholar
• Southgate, E., & Hopwood, M. (2001). The role of folk pharmacology and lay experts in harm reduction: Sydney gay drug using networks. International Journal of Drug Policy, 12(4), 321–335.
   Google Scholar
• Webster, A., Douglas, C., & Lewis, G. (2009). Making sense of medicines: ‘Lay pharmacology’ and narratives of safety and efficacy. Science as Culture, 18(2), 233–247.
   Google Scholar
• Weiner, K. (2011). The subject of functional foods: Accounts of consuming foods containing phytosterols. Sociological Research Online, 16(2), 7. Retrieved from http://www.socresonline.org.uk/16/2/7.html
   Google Scholar
• Will, C. (2005). Arguing about the evidence: Readers, writers and inscription devices in coronary heart disease risk assessment. Sociology of Health & Illness, 27(6), 780–801.
   Google Scholar